Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Artificial Intelligence Oversight At FDA Will Require Continuous Algorithm Validation, Califf Says
Feb 13 2024
•
By
Derrick Gingery
Robert Califf said industry needs to be more accountable for the FDA to deal with AI. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from AI
More from Advanced Technologies